We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.09B
AUM Growth
+$15.8M
Cap. Flow
-$86M
Cap. Flow %
-4.12%
Top 10 Hldgs %
18.08%
Holding
266
New
20
Increased
45
Reduced
134
Closed
56

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$18.8M
2
TENB icon
Tenable Holdings
TENB
+$16.8M
3
LIVN icon
LivaNova
LIVN
+$14M
4
FN icon
Fabrinet
FN
+$13.9M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
ACDC icon
ProFrac Holding
ACDC
+$26.1M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$21.4M
3
CUBI icon
Customers Bancorp
CUBI
+$16M
4
MTSI icon
MACOM Technology Solutions
MTSI
+$14.6M
5
PRFT
Perficient Inc
PRFT
+$13.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.06%
2 Technology 16.79%
3 Industrials 15.69%
4 Consumer Discretionary 14.06%
5 Financials 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRKS icon
76
United Parks & Resorts
PRKS
$2.13B
$12.5M 0.6%
203,565
-4,441
-2% -$271K
RHP icon
77
Ryman Hospitality Properties
RHP
$7.99B
$12.4M 0.59%
138,245
-729
-0.5% -$64.6K
LIVN icon
78
LivaNova
LIVN
$4.43B
$12.1M 0.58%
+277,388
New +$14M
WOOF icon
79
Petco
WOOF
$760M
$11.8M 0.57%
1,313,512
-17,151
-1% -$177K
TRNO icon
80
Terreno Realty
TRNO
$7.94B
$11.6M 0.55%
178,950
-4,373
-2% -$273K
ICUI icon
81
ICU Medical
ICUI
$3.94B
$11.3M 0.54%
68,572
+68,457
+59,528% +$11.8M
INDI icon
82
indie Semiconductor
INDI
$809M
$10.8M 0.52%
+1,023,121
New +$9.14M
ZUO
83
DELISTED
Zuora, Inc.
ZUO
$10.7M 0.51%
1,085,929
+1,081,129
+22,524% +$9.06M
FIVE icon
84
Five Below
FIVE
$11.2B
$10.5M 0.5%
50,849
-13,588
-21% -$2.68M
UTZ icon
85
Utz Brands
UTZ
$638M
$10.4M 0.5%
629,440
-15,844
-2% -$262K
IPGP icon
86
IPG Photonics
IPGP
$4.43B
$10.3M 0.49%
83,356
+19,982
+32% +$2.31M
FA icon
87
First Advantage
FA
$3.83B
$9.69M 0.46%
693,782
-135,856
-16% -$1.84M
SKYT icon
88
SkyWater Technology
SKYT
$1.54B
$9.57M 0.46%
841,160
+51,297
+6% +$575K
SKWD icon
89
Skyward Specialty Insurance
SKWD
$2.4B
$9.55M 0.46%
+436,686
New +$8.49M
AMBA icon
90
Ambarella
AMBA
$2.71B
$9.19M 0.44%
118,659
+25,536
+27% +$2.19M
TTI icon
91
TETRA Technologies
TTI
$1.37B
$9.06M 0.43%
3,418,738
+47,161
+1% +$164K
LIND icon
92
Lindblad Expeditions
LIND
$1.82B
$8.89M 0.43%
930,171
-3,629
-0.4% -$36.5K
CYTK icon
93
Cytokinetics
CYTK
$10.9B
$8.36M 0.4%
237,617
-234,693
-50% -$9.57M
DEN
94
DELISTED
Denbury Inc.
DEN
$8.29M 0.4%
94,655
-25,687
-21% -$2.16M
OFIX icon
95
Orthofix Medical
OFIX
$468M
$8.26M 0.4%
+493,393
New +$9.66M
YETI icon
96
Yeti Holdings
YETI
$3.87B
$8.08M 0.39%
201,949
-84,388
-29% -$3.48M
CUTR
97
DELISTED
Cutera, Inc.
CUTR
$7.77M 0.37%
328,858
-8,324
-2% -$266K
ARIS
98
DELISTED
Aris Water Solutions
ARIS
$7.7M 0.37%
987,954
-46,104
-4% -$595K
VAL icon
99
Valaris
VAL
$5.3B
$7.41M 0.36%
+113,850
New +$7.94M
MSFT icon
100
Microsoft
MSFT
$2.93T
$6.56M 0.31%
22,752
-349
-2% -$89K
2 3
4
5 6

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, Emerald Advisers held 266 positions worth $2.09B, up 0.76% from $2.07B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers withdrew a net $86M in Q1 2023, closing 56 positions and reducing 134 holdings. Its most notable exit was ProFrac Holding, an estimated $26.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Emerald Advisers opened a new position in LivaNova worth $12.1M.

  • Emerald Advisers's largest Q1 2023 buy was LivaNova: 277,388 shares worth $12.1M.
  • Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2023, an estimated $18.8M increase.
  • Emerald Advisers's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $21.4M.
  • Emerald Advisers fully exited ProFrac Holding in Q1 2023, selling an estimated $26.1M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.09B portfolio in Q1 2023.
  • Emerald Advisers opened 20 new positions and closed 56 in Q1 2023.
  • Emerald Advisers's portfolio value rose 0.76% quarter-over-quarter to $2.09B.

Based on Emerald Advisers's 13F filing for Q1 2023, filed 4 May 2023.